Observational study to analyse the opioid titration process in the treatment of breakthrough pain of cancer patients in clinical practice

Most cancer patients experience moderate to severe chronic pain during their disease. It occurs in 30% to 40% of patients at the time of diagnosis, and in up to 75% of cases of advanced disease. Control of this chronic pain can be achieved in most cancer patients with adequate analgesic treatment [1-6].